Barry G. Arnason to Drug Administration Schedule
This is a "connection" page, showing publications Barry G. Arnason has written about Drug Administration Schedule.
Connection Strength
0.024
-
Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting multiple sclerosis: a multicenter, randomized, double-blind, parallel-group pilot study. Clin Ther. 2008 Jun; 30(6):1102-12.
Score: 0.016
-
Immunoaugmenting effect of FK 506 on experimental allergic encephalomyelitis in Lewis rats. J Autoimmun. 1998 Aug; 11(4):329-34.
Score: 0.008